Histone deacetylases as regulators of inflammation and immunity
- PMID: 21570914
- DOI: 10.1016/j.it.2011.04.001
Histone deacetylases as regulators of inflammation and immunity
Abstract
Histone deacetylases (HDACs) remove an acetyl group from lysine residues of target proteins to regulate cellular processes. Small-molecule inhibitors of HDACs cause cellular growth arrest, differentiation and/or apoptosis, and some are used clinically as anticancer drugs. In animal models, HDAC inhibitors are therapeutic for several inflammatory diseases, but exacerbate atherosclerosis and compromise host defence. Loss of HDAC function has also been linked to chronic lung diseases in humans. These contrasting effects might reflect distinct roles for individual HDACs in immune responses. Here, we review the current understanding of innate and adaptive immune pathways that are regulated by classical HDAC enzymes. The objective is to provide a rationale for targeting (or not targeting) individual HDAC enzymes with inhibitors for future immune-related applications.
Copyright © 2011 Elsevier Ltd. All rights reserved.
Similar articles
-
Role of histone deacetylases in vascular cell homeostasis and arteriosclerosis.Cardiovasc Res. 2011 Jun 1;90(3):413-20. doi: 10.1093/cvr/cvr003. Epub 2011 Jan 13. Cardiovasc Res. 2011. PMID: 21233251 Review.
-
HDAC inhibitors for the treatment of cancer.Curr Opin Investig Drugs. 2003 Dec;4(12):1422-7. Curr Opin Investig Drugs. 2003. PMID: 14763127 Review.
-
Epigenetic regulation of airway inflammation.Curr Opin Immunol. 2007 Dec;19(6):694-700. doi: 10.1016/j.coi.2007.07.016. Epub 2007 Aug 27. Curr Opin Immunol. 2007. PMID: 17720468 Review.
-
Function of histone deacetylase inhibitors in inflammation.Crit Rev Immunol. 2011;31(3):233-63. doi: 10.1615/critrevimmunol.v31.i3.40. Crit Rev Immunol. 2011. PMID: 21740352 Review.
-
Targeting histone deacetylases for the treatment of cancer and inflammatory diseases.J Cell Physiol. 2006 Dec;209(3):611-6. doi: 10.1002/jcp.20781. J Cell Physiol. 2006. PMID: 17001696 Review.
Cited by
-
A Novel Class I HDAC Inhibitor, AW01178, Inhibits Epithelial-Mesenchymal Transition and Metastasis of Breast Cancer.Int J Mol Sci. 2024 Jun 30;25(13):7234. doi: 10.3390/ijms25137234. Int J Mol Sci. 2024. PMID: 39000339 Free PMC article.
-
Epigenetic mechanisms underlying diet-sourced compounds in the prevention and treatment of gastrointestinal cancer.Anticancer Agents Med Chem. 2012 Dec;12(10):1203-10. doi: 10.2174/187152012803833053. Anticancer Agents Med Chem. 2012. PMID: 22931412 Free PMC article.
-
Genome-Wide Association Studies of Somatic Cell Count in the Assaf Breed.Animals (Basel). 2021 May 24;11(6):1531. doi: 10.3390/ani11061531. Animals (Basel). 2021. PMID: 34074014 Free PMC article.
-
HDAC inhibitors as antifibrotic drugs in cardiac and pulmonary fibrosis.Ther Adv Chronic Dis. 2019 Jul 18;10:2040622319862697. doi: 10.1177/2040622319862697. eCollection 2019. Ther Adv Chronic Dis. 2019. PMID: 31367296 Free PMC article. Review.
-
Comprehensive bioinformatics analyses reveal immune genes responsible for altered immune microenvironment in intervertebral disc degeneration.Mol Genet Genomics. 2022 Sep;297(5):1229-1242. doi: 10.1007/s00438-022-01912-3. Epub 2022 Jun 29. Mol Genet Genomics. 2022. PMID: 35767190 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources